Navigation Links
Innovia Receives FDA Clearance For The InnoPort(TM)
Date:6/2/2009

New medical device will facilitate single port access laparoscopic surgery

MIAMI, June 2 /PRNewswire/ -- Innovia LLC, a privately held biomaterials-based medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the InnoPort(TM) to facilitate single port access laparoscopy.

The InnoPort is inserted into the abdomen to perform laparoscopic surgery through one small incision--instead of multiple incisions--with the goal of minimizing scarring, pain, recovery time, and complication risk to the patient. The port is enabled by Quatromer(R), one of Innovia's proprietary biopolymers. The biopolymer's patented flexibility grants the physician unrestricted access to the abdominal cavity with up to three rigid and/or articulating instruments.

"In the time-sensitive and no-nonsense environment of the OR, the bell-and-whistle features of existing ports were overly complicated and tended to slow down my procedures. I needed a port that was simple and reliable, and this was the inspiration for the InnoPort," said David Edelman, MD, General Surgeon and inventor of the device. "Compared to other available single access ports, the InnoPort seems to be the easiest to use. The one-piece, stopper-shaped device can be inserted quickly, and its flexibility allows me to manipulate my instruments to extreme angulations without crowding one another in the working space, all while maintaining a tight insufflation seal."

"Our staff is especially proud to have worked with Dr. Edelman to develop the InnoPort," adds Len Pinchuk, Ph.D., D.Sc., President/CEO of Innovia. "We believe that the device will fulfill unmet clinical needs for simplicity and efficacy in the rapidly expanding single incision laparoscopic space and are confident that physicians will agree."

The InnoPort is scheduled for commercialization in the United States this year with expansion to Europe thereafter. For further information, please contact Innovia.

ABOUT INNOVIA LLC

Innovia is a privately held biomaterials-based medical device company that specializes in the development of innovative medical devices incorporating proprietary novel biomaterials. Innovia's experienced and highly specialized engineers, scientists, and chemists have been responsible for over $15 billion in revenue throughout their careers in the medical device industry. Please visit www.innovia-llc.com to learn more about the Company.


'/>"/>
SOURCE Innovia LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
2. Respected Surgeon Receives Emmy Nomination
3. Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA)
4. LA BioMed researcher receives clinical teaching award
5. SAFC Pharmas St. Louis HPAPI Conjugates Facility Receives SafeBridge Certification
6. ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
7. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
8. Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D.
9. Dalcon Receives Unified Communications Magazines Product of the Year Award
10. InfuSystem Receives Accreditation from the Community Health Accreditation Program (CHAP)
11. Childrens Health Fund Receives $500,000 from the Starr International Foundation to Support South Bronx Homeless Health Care Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: